Note from the BJOT Editor-Chief BJOT, like many major occupational therapy and rehabilitation journals, has already adopted guidelines for reporting. Since 2015, when the journal moved to SAGE for publication, BJOT has conformed to the ICMJE requirement (International Committee of Medical Journal Editors[ICMJE], n.d.) that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication (see BJOT Submission Guidelines at bjo.sagepub.com for further information). We are reprinting this editorial to join our professional colleagues at the journals listed below in explaining why registration is so important for clinical trials.
In addition to publishing clinical trials, BJOT welcomes the submission of pilot/feasibility studies for clinical trials and RCT protocols and will spotlight examples in an online e-collection. Authors considering submission of a pilot or feasibility study for a future trial are not required to register this but are encouraged to contact the journal prior to submission if unsure.
This editorial is reprinted from the Archives of Physical Medicine and Rehabilitation, 96, 2093 . http://dx.doi.org/10.1016 /j.apmr.2015 .005 by permission.
Registration of a clinical trial requires that researchers document key aspects of their research methodology in a publicly available database. In the words of the International Committee of Medical Journal Editors, the registration of clinical trials is needed to prevent selective publication and selective reporting of research outcomes, to prevent unnecessary duplication of research efforts, to help patients and the public know what trials are planned or ongoing into which they might want to enroll, and to help give ethics review boards considering approval of new studies a view of similar work and data relevant to the research they are considering. (International Committee of Medical Journal Editors, n.d., para. 5) Any journal that wants to follow the International Committee of Medical Journal Editors guidelines must require registration, and authors who state that they abide by the Declaration of Helsinki must register their trial before the first patient is enrolled. Trial registration is also required by regulations of the U.S. Food and Drug Administration, European Union, and World Health Organization (https://clinicaltrials.gov/ct2/manage-recs/ background).
Some rehabilitation research consortiums (e.g., International Society of Physiotherapy Journal Editors) have transitioned to mandatory trial registration. We refer our readers to their 2013 editorial that clearly outlines the case for mandatory trial registration and the details of how authors may comply (Costa et al., 2013) .
In brief, trial registration has been gaining adherents since the concept was proposed in the late 1990s. For our purposes (please refer to the instructions for authors for each journal because this definition may vary), a clinical trial is defined as ''any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes'' (World Health Organization, 2015, para. 3) . Therefore, cohort and retrospective studies without an intervention do not require registration, and neither do observational studies of clinical care. However, studies of human subjects with prospective assignment of an intervention by the investigators, regardless of the size of the trial or method of assignment, must be registered.
There are a number of free websites where researchers can register their trials. Perhaps the most frequently used in the United States are the following: ClinicalTrials.gov (available at https://clinicaltrials.gov/ct2/manage-recs) and International Clinical Trials Registry Platform (available at http://www.who.int/ictrp/en/). There are also country-specific sites; however, most registries will take data from any nation.
This editorial serves as a notice to authors that they must register their trials soon. Starting January 1, 2016, all manuscripts reporting clinical trials must be registered before submission. For trials that are underway and are already enrolling patients, registration will be retrospective. This interim step achieves 2 goals: (1) to educate authors about trial registration, and (2) to provide documentation of original study designs and primary outcome measures.
This transition period will end January 1, 2017. By that time, all journals publishing this editorial will only consider clinical trials that have been registered before the first patient is enrolled.
We take these steps with the goal of enhancing the quality of the science we publish and improving the health of patients around the world.
